Navigation Links
Regulus Announces $80.9 Million in Total Gross Proceeds from IPO and Other Recent Financial Transactions
Date:11/5/2012

s and leverages the oligonucleotide drug discovery and development expertise of its founding companies, Alnylam Pharmaceuticals (NASDAQ: ALNY) and Isis Pharmaceuticals (NASDAQ: ISIS). Regulus is advancing microRNA therapeutics toward clinical development in several areas, including oncology, fibrosis, hepatitis C and metabolic diseases. Regulus has formed strategic alliances with AstraZeneca, GlaxoSmithKline and Sanofi and a research collaboration with Biogen Idec.

For more information, please visit http://www.regulusrx.com.

Forward-Looking Statements

Statements contained in this press release regarding matters that are not historical facts are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, including statements associated with Regulus' expectations regarding its financial position and the future therapeutic and commercial potential of Regulus' business plans, technologies and intellectual property related to microRNA therapeutics being discovered and developed by Regulus.  Because such statements are subject to risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements. Words such as "believes," "anticipates," "plans," "expects," "intends," "will," "goal," "potential" and similar expressions are intended to identify forward-looking statements. These forward-looking statements are based upon Regulus' current expectations and involve assumptions that may never materialize or may prove to be incorrect.  Actual results and the timing of events could differ materially from those anticipated in such forward-looking statements as a result of various risks and uncertainties, which include, without limitation, risks associated with the process of discovering, developing and commercializing drugs that are safe and effective for use as human therapeuti
'/>"/>

SOURCE Regulus Therapeutics Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Regulus Therapeutics Forms Strategic Alliance for Discovery, Development and Commercialization of microRNA Therapeutics with AstraZeneca
2. Biogen Idec and Regulus Therapeutics Form Collaboration to Explore microRNA Biomarkers for Disease Monitoring and Response to Therapy
3. Regulus Presents New Preclinical Data on miR-21 at Kidney Week 2012
4. Precision Optics Corporation Announces $1 Million Order for Microprecision™ Based Endoscopes
5. Young Innovations, Inc. Announces Record Sales and EPS for the Quarter Ended March 31, 2012
6. JDRF Announces Research Collaboration with Dexcom, Inc. to Develop "Smart Transmitter" Technology to Accelerate Artificial Pancreas Studies
7. Misonix Announces New Distribution Agreement For Panama
8. University of Maryland BioPark Announces MedImmunes Dr. Bahija Jallal as Newest Member of Board of Directors for UM Health Sciences Research Park
9. Novelos Therapeutics Announces Successful Completion of First Cohort In Lung Cancer Trial With I-124-CLR1404 (LIGHT) Cancer-Targeted PET Imaging Agent at UW Carbone Cancer Center
10. Boston Scientific Announces CE Mark and European Launch of Emerge™ PTCA Dilatation Catheter
11. Soligenix Announces Further Progress with ThermoVax™ for Long-Term Vaccine ThermoStability
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... Aug. 27, 2014 Reportlinker.com announces that ... its catalogue: Global Orthopedic Soft Tissue ... http://www.reportlinker.com/p02316671/Global-Orthopedic-Soft-Tissue-Repair-Devices-Market-2014-2018.html About Orthopedic Soft ... mass of cells that connect, support, or surround ... tissues such as tendons, ligaments, cartilage, fascia, and ...
(Date:8/27/2014)... Aug. 27, 2014  Decision Resources Group finds ... oncology, hematology-oncology, rheumatology, gastroenterology, endocrinology and nephrology) expect ... a biosimilar has been assessed in to be ... choose to prescribe. Other key ... Acceptance of Biosimilars Across Physician Specialties ...
(Date:8/27/2014)... , Aug. 27, 2014 Decision Resources Group ... the Memphis health system and ... clinical integration, with rivals Methodist Le Bonheur Healthcare and ... groups to coordinate patient care. In addition, a national ... the most health plan enrollment in the ...
Breaking Medicine Technology:Global Orthopedic Soft Tissue Repair Devices Market 2014-2018 2Global Orthopedic Soft Tissue Repair Devices Market 2014-2018 3Global Orthopedic Soft Tissue Repair Devices Market 2014-2018 4Global Orthopedic Soft Tissue Repair Devices Market 2014-2018 5Surveyed Physicians Expect to Choose Between Future Biosimilars Based on Robustness and Number of Clinical Trials 2Memphis-area Health Systems Turn Attention to Clinical Integration 2
... Must for Clinical Trials Management, WASHINGTON, ... Centers (AAHC) today launched a new Clinical ... center leaders,research administrators, and chief compliance officers ... for the,research enterprise, particularly to manage and ...
... and limited launch in Italy continue, FRANKLIN, Mass., ... announced today that it will defer the commencement of ... prevention of,Contrast-Induced Nephropathy (CIN). The company continues to support ... well,as the limited market launch of RenalGuard in Europe, ...
Cached Medicine Technology:New AAHC Toolkit Available to Optimize Clinical Research Administration 2PLC Systems Defers Pivotal Study of RenalGuard(TM) in the U.S. 2PLC Systems Defers Pivotal Study of RenalGuard(TM) in the U.S. 3PLC Systems Defers Pivotal Study of RenalGuard(TM) in the U.S. 4PLC Systems Defers Pivotal Study of RenalGuard(TM) in the U.S. 5
(Date:8/27/2014)... 27, 2014 Today, Zane Benefits, the ... compliance tips for administering a premium reimbursement plan. ... full effect, compliance is top of mind for employers, ... individual health insurance and premium reimbursement, there are important ... the 35 minute webinar, Zane Benefits President, Rick Lindquist, ...
(Date:8/27/2014)... Recently, iFitDress.com, a professional company of women’s ... of romantic bridal gowns . To top it ... (up to 66 percent off) when buying the company’s ... has been updated with these new items. All its ... that all clients can gain an enjoyable shopping experience ...
(Date:8/27/2014)... (PRWEB) August 27, 2014 New Jersey’s ... at The Ridgewood County Club during The Barclays – ... in each of the tournament’s four rounds, stepped his ... Horizon Blue Cross Blue Shield of New Jersey (Horizon ... Hoffmann, a Wyckoff native playing before family and friends ...
(Date:8/27/2014)... Young adults who struggled with depression in adolescence appear ... reporting. The findings might improve understanding of depression ... and treat the illness, according to the University of ... scans on 30 volunteers, ages 18 to 23, who ... group of 23 young adults who never had depression. ...
(Date:8/27/2014)... August 27, 2014 Michigan Head & Neck ... children of a local elementary school by ensuring they have ... School has year-round attendance, and Michigan Head & Neck Institute ... the new school year. , "There are a lot of ... a great way to give back to our community," said ...
Breaking Medicine News(10 mins):Health News:Zane Benefits Announces Upcoming Webinar on Compliance 2Health News:Promotion For Romantic Bridal Gowns Launched By Professional Company iFitDress.com 2Health News:Morgan Hoffmann, PGA TOUR Pro & Wyckoff Native, golfs and walks his way to top 10 finish at The Barclays while raising additional $7,500 for charity 2Health News:Study: Young Adults Who Had Depression Have 'Hyper-Connected' Brain Networks 2Health News:Michigan Head & Neck Institute is Conducting Their 2nd Annual School Supplies Drive at Their Facility to Benefit Local Year-Round Elementary School Students 2
... people, animals, and our environment has created a new ... inextricably and globally interconnected, without borders. It is against ... multidisciplinary effort to attain optimal health of humans, animals ... a session at the annual meeting of the American ...
... becomes more common. Swedish scientist Laura Fratiglioni has shown that ... Factors from blood pressure and weight to the degree of ... gets older. The lengthening of the average life span ... of aging related disorders, one of which is cognitive impairment ...
... researchers generally credit the desire for smaller families for the ... suggests that prevention of unwanted births may actually be a ... birth control means that people have better control of when ... the Initiative in Population Research at Ohio State University. ...
... This release is available in French . ... continues to spread in cities around the world. Vanier Canada ... between cities, water and health at the THINK CANADA Press ... (AAAS) conference Sunday. Mulligan is a PhD student at ...
... more time to conduct in overweight and obese patients ... at Hospital for Special Surgery in New York. The ... Orthopaedic Surgeons annual meeting, held Feb. 15-19 in San ... scheduling surgeries, operating room utilization and personnel staffing, and ...
... developed an optical technology that provides unprecedented images under ... to detect and examine skin lesions to determine whether ... the suspected tumor out of the skin and analyze ... roughly one-foot-long cylindrical probe is placed in contact with ...
Cached Medicine News:Health News:One Health: From ideas to implementation, rhetoric to reality 2Health News:One Health: From ideas to implementation, rhetoric to reality 3Health News:One Health: From ideas to implementation, rhetoric to reality 4Health News:Look after your brain 2Health News:Family planning programs have success in developing countries, but need to be expanded 2Health News:Family planning programs have success in developing countries, but need to be expanded 3Health News:Is the link between poverty and water-related disease making rich people sick? 2Health News:Knee replacement surgeries take more time, are more costly in overweight individuals 2Health News:Knee replacement surgeries take more time, are more costly in overweight individuals 3Health News:A new high-resolution method for imaging below the skin using a liquid lens 2
Enzyme Immunoassay of Tissue Plasminogen Activator Antigen by ELISA Method, 96 tests....
Citrated human plasma for the calibration of vWF assays by the immuno-turbidimetric method on STA© analyzers.(STA© Liatest© vWF #0518)....
Heparin-Platelet Factor 4 Induced Antibody...
Control Plasma for Assays of Low MolecularWeight Heparins (LMWH) using Anti-Xa Method on STA© Analyzers....
Medicine Products: